212 related articles for article (PubMed ID: 20564632)
1. Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth?
Gripp S; Mjartan S; Boelke E; Willers R
Cancer; 2010 Jul; 116(13):3251-6. PubMed ID: 20564632
[TBL] [Abstract][Full Text] [Related]
2. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression.
Gripp S; Moeller S; Bölke E; Schmitt G; Matuschek C; Asgari S; Asgharzadeh F; Roth S; Budach W; Franz M; Willers R
J Clin Oncol; 2007 Aug; 25(22):3313-20. PubMed ID: 17664480
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
4. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
5. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
6. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
8. Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer.
Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1169-76. PubMed ID: 18938045
[TBL] [Abstract][Full Text] [Related]
9. A prospective survey of radiotherapy in Sweden.
Acta Oncol; 1996; 35 Suppl 6():47-56. PubMed ID: 9154085
[TBL] [Abstract][Full Text] [Related]
10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
11. The role of palliative radiotherapy in locally advanced non-small cell lung cancer.
Cetingoz R; Kentli S; Uruk O; Demirtas E; Sen M; Kinay M
Neoplasma; 2001; 48(6):506-10. PubMed ID: 11949846
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of survival prediction by palliative radiation oncologists.
Chow E; Davis L; Panzarella T; Hayter C; Szumacher E; Loblaw A; Wong R; Danjoux C
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):870-3. PubMed ID: 15708268
[TBL] [Abstract][Full Text] [Related]
14. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.
Komosinska K; Kepka L; Niwinska A; Pietrzak L; Wierzchowski M; Tyc-Szczepaniak D; Kaczmarczyk A; Bujko K
Acta Oncol; 2010 Apr; 49(3):382-8. PubMed ID: 20397770
[TBL] [Abstract][Full Text] [Related]
16. Radiosurgery for brain metastases from primary lung carcinoma.
Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
[TBL] [Abstract][Full Text] [Related]
17. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study.
Mohanti BK; Umapathy H; Bahadur S; Thakar A; Pathy S
Radiother Oncol; 2004 Jun; 71(3):275-80. PubMed ID: 15172142
[TBL] [Abstract][Full Text] [Related]
18. [Single-dose palliative radiotherapy in inoperable non-small-cell lung carcinoma].
Scolaro T; Bacigalupo A; Giudici S; Guenzi M; Vitale V
Radiol Med; 1995 Dec; 90(6):808-11. PubMed ID: 8685468
[TBL] [Abstract][Full Text] [Related]
19. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
20. 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri.
Onsrud M; Hagen B; Strickert T
Gynecol Oncol; 2001 Jul; 82(1):167-71. PubMed ID: 11426980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
